WILD vs. CGX, ZUM, CGO, RAY.A, FORA, Y, PNC.B, EQ, AXV, and GAME
Should you be buying WildBrain stock or one of its competitors? The main competitors of WildBrain include Cineplex (CGX), ZoomerMedia (ZUM), Cogeco (CGO), Stingray Group (RAY.A), VerticalScope (FORA), Yellow Pages (Y), Postmedia Network Canada Corp Class NC (PNC.B), EQ (EQ), Axion Ventures (AXV), and GameSquare (GAME). These companies are all part of the "communication services" sector.
WildBrain vs.
Cineplex (TSE:CGX) and WildBrain (TSE:WILD) are both small-cap communication services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.
Cineplex currently has a consensus target price of C$20.00, suggesting a potential upside of 105.97%. WildBrain has a consensus target price of C$1.88, suggesting a potential downside of 3.42%. Given Cineplex's stronger consensus rating and higher possible upside, equities research analysts plainly believe Cineplex is more favorable than WildBrain.
Cineplex pays an annual dividend of C$1.80 per share and has a dividend yield of 18.5%. WildBrain pays an annual dividend of C$0.08 per share and has a dividend yield of 4.1%. Cineplex pays out -302.9% of its earnings in the form of a dividend. WildBrain pays out -9.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cineplex is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Cineplex and Cineplex both had 1 articles in the media. Cineplex's average media sentiment score of 0.00 beat WildBrain's score of -0.33 indicating that Cineplex is being referred to more favorably in the media.
Cineplex has higher revenue and earnings than WildBrain. Cineplex is trading at a lower price-to-earnings ratio than WildBrain, indicating that it is currently the more affordable of the two stocks.
Cineplex has a net margin of -2.83% compared to WildBrain's net margin of -38.77%. WildBrain's return on equity of 3,013.26% beat Cineplex's return on equity.
Cineplex has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500. Comparatively, WildBrain has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500.
Cineplex received 776 more outperform votes than WildBrain when rated by MarketBeat users. Likewise, 72.52% of users gave Cineplex an outperform vote while only 20.00% of users gave WildBrain an outperform vote.
24.3% of Cineplex shares are held by institutional investors. Comparatively, 45.4% of WildBrain shares are held by institutional investors. 1.9% of Cineplex shares are held by company insiders. Comparatively, 1.3% of WildBrain shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Cineplex beats WildBrain on 14 of the 19 factors compared between the two stocks.
Get WildBrain News Delivered to You Automatically
Sign up to receive the latest news and ratings for WILD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
WildBrain Competitors List
Related Companies and Tools
This page (TSE:WILD) was last updated on 3/20/2025 by MarketBeat.com Staff
